Treace Medical Concepts
TMCI
62 hedge funds and large institutions have $351M invested in Treace Medical Concepts in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 15 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 16
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.73% less ownership
Funds ownership: 25.43% → 24.7% (-0.73%)
12% less capital invested
Capital invested by funds: $398M → $351M (-$47.5M)
13% less funds holding
Funds holding: 71 → 62 (-9)
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.1M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
+$15.7M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$8.26M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$3.19M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$17.5M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$10.1M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.25M |
| 4 |
CCM
CAAS Capital Management
New York
|
-$4.69M |
| 5 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$3.71M |
TMCI Hedge Fund Activity: Q3 2021 in Review
62 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q3 2021, worth a combined $351M — down 12% from $398M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of TMCI and 7 opened new positions — a net loss of 8 holders — while 16 trimmed existing stakes and 28 added.
The largest buyer was Vanguard Group, adding an estimated $16.1M. The largest seller was Jennison Associates, exiting entirely with an estimated $17.5M sold.
- 62 institutional investors held Treace Medical Concepts (TMCI) as of Q3 2021, down from 71 in Q2 2021.
- Funds reported $351M of Treace Medical Concepts stock for Q3 2021, down 12% quarter-over-quarter.
- 7 funds opened new Treace Medical Concepts positions in Q3 2021 and 15 closed out, a net change of -8 holders.
- The largest Treace Medical Concepts buyer in Q3 2021 was Vanguard Group, an estimated $16.1M added.
- The largest Treace Medical Concepts seller in Q3 2021 was Jennison Associates, an estimated $17.5M sold.
Based on aggregated 13F filings for Q3 2021.